These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 14964783)

  • 1. Artificial neural networks: non-linear QSAR studies of HEPT derivatives as HIV-1 reverse transcriptase inhibitors.
    Douali L; Villemin D; Zyad A; Cherqaoui D
    Mol Divers; 2004; 8(1):1-8. PubMed ID: 14964783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QSAR for anti-HIV activity of HEPT derivatives.
    Bazoui H; Zahouily M; Boulajaaj S; Sebti S; Zakarya D
    SAR QSAR Environ Res; 2002 Oct; 13(6):567-77. PubMed ID: 12479372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative QSAR based on neural networks for the anti-HIV activity of HEPT derivatives.
    Douali L; Villemin D; Cherqaoui D
    Curr Pharm Des; 2003; 9(22):1817-26. PubMed ID: 12871199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neural networks: Accurate nonlinear QSAR model for HEPT derivatives.
    Douali L; Villemin D; Cherqaoui D
    J Chem Inf Comput Sci; 2003; 43(4):1200-7. PubMed ID: 12870912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel simple QSAR model for the prediction of anti-HIV activity using multiple linear regression analysis.
    Afantitis A; Melagraki G; Sarimveis H; Koutentis PA; Markopoulos J; Igglessi-Markopoulou O
    Mol Divers; 2006 Aug; 10(3):405-14. PubMed ID: 16896545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 3D QSAR study of a series of HEPT analogues: the influence of conformational mobility on HIV-1 reverse transcriptase inhibition.
    Kireev DB; Chrétien JR; Grierson DS; Monneret C
    J Med Chem; 1997 Dec; 40(26):4257-64. PubMed ID: 9435895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolutionary optimization, backpropagation, and data preparation issues in QSAR modeling of HIV inhibition by HEPT derivatives.
    Weekes D; Fogel GB
    Biosystems; 2003 Nov; 72(1-2):149-58. PubMed ID: 14642664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QSAR models for HEPT derivates as NNRTI inhibitors based on Monte Carlo method.
    Toropova AP; Toropov AA; Veselinović JB; Miljković FN; Veselinović AM
    Eur J Med Chem; 2014 Apr; 77():298-305. PubMed ID: 24657566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HEPT derivatives as non-nucleoside inhibitors of HIV-1 reverse transcriptase: QSAR studies agree with the crystal structures.
    Gaudio AC; Montanari CA
    J Comput Aided Mol Des; 2002 Apr; 16(4):287-95. PubMed ID: 12400858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QSAR study on some anti-HIV HEPT analogues using physicochemical and topological parameters.
    Gayen S; Debnath B; Samanta S; Jha T
    Bioorg Med Chem; 2004 Mar; 12(6):1493-503. PubMed ID: 15018923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-nucleoside HIV-1 reverse transcriptase inhibitors, Part 7. Synthesis, antiviral activity, and 3D-QSAR investigations of novel 6-(1-naphthoyl) HEPT analogues.
    Ji L; Chen FE; Feng XQ; De Clercq E; Balzarini J; Pannecouque C
    Chem Pharm Bull (Tokyo); 2006 Sep; 54(9):1248-53. PubMed ID: 16946529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational study of the HIV-1 reverse transcriptase inhibitor 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT).
    Lawtrakul L; Hannongbua S; Beyer A; Wolschann P
    Biol Chem; 1999 Feb; 380(2):265-7. PubMed ID: 10195434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QSAR based on multiple linear regression and PLS methods for the anti-HIV activity of a large group of HEPT derivatives.
    Luco JM; Ferretti FH
    J Chem Inf Comput Sci; 1997; 37(2):392-401. PubMed ID: 9090857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development of HEPT-type HIV non-nucleoside reverse transcriptase inhibitors and its implications for DABO family.
    Chen W; Zhan P; Wu J; Li Z; Liu X
    Curr Pharm Des; 2012; 18(27):4165-86. PubMed ID: 22621244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hologram quantitative structure-activity relationships investigations of non-nucleoside reverse transcriptase inhibitors.
    Pungpo P; Hannongbua S; Wolschann P
    Curr Med Chem; 2003 Sep; 10(17):1661-77. PubMed ID: 12871115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of artificial neural networks in a QSAR study of anti-HIV activity for a large group of HEPT derivatives.
    Jalali-Heravi M; Parastar F
    J Chem Inf Comput Sci; 2000; 40(1):147-54. PubMed ID: 10661561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Docking, molecular dynamics and quantitative structure-activity relationship studies for HEPTs and DABOs as HIV-1 reverse transcriptase inhibitors.
    Mao Y; Li Y; Hao M; Zhang S; Ai C
    J Mol Model; 2012 May; 18(5):2185-98. PubMed ID: 21947448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diverse combinatorial design, synthesis and in vitro evaluation of new HEPT analogues as potential non-nucleoside HIV-1 reverse transcription inhibitors.
    Puig-de-la-Bellacasa R; Giménez L; Pettersson S; Pascual R; Gonzalo E; Esté JA; Clotet B; Borrell JI; Teixidó J
    Eur J Med Chem; 2012 Aug; 54():159-74. PubMed ID: 22652226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-HIV activity of HEPT, TIBO, and cyclic urea derivatives: structure-property studies, focused combinatorial library generation, and hits selection using substructural molecular fragments method.
    Solov'ev VP; Varnek A
    J Chem Inf Comput Sci; 2003; 43(5):1703-19. PubMed ID: 14502505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationally designed dual inhibitors of HIV reverse transcriptase and integrase.
    Wang Z; Bennett EM; Wilson DJ; Salomon C; Vince R
    J Med Chem; 2007 Jul; 50(15):3416-9. PubMed ID: 17608468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.